India, Nov. 3 -- A day after PM Modi's 'katta' jibe at Congress and RJD, Congress president Mallikarjun Kharge on Monday fired back by saying Bihar chief minister Nitish Kumar has surrendered to the B... Read More
New Delhi, Nov. 3 -- Telecom major Bharti Airtel on Monday, November 3, reported a 89 per cent year-on-year (YoY) rise in its consolidated profit for Q2FY26 to Rs.6,791.7 crore from Rs.3,593.2 crore i... Read More
Hyderabad, Nov. 3 -- Telangana Jagruthi President and MLC K Kavitha has expressed condolences to the families of the deceased in the road accident that occurred this morning in Rangareddy district. Ac... Read More
New Delhi, Nov. 3 -- The Enforcement Directorate (ED) has attached 40 properties worth about Rs 3,084 crore linked to entities of the Reliance Anil Ambani Group in connection with an alleged money lau... Read More
Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ACTRN12625001168448) titled 'Evaluating the impact of Artificial Intelligence (AI) assistance in car... Read More
Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN17218321) titled 'Evaluating tools to communicate scleroderma research results to patients - t... Read More
Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN18053239) titled 'A high-protection sunscreen with natural ingredients helps reduce dark patch... Read More
Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ACTRN12625001169437) titled 'Evaluating the impact of topical dry eye therapies on tear film quality... Read More
Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN83128058) titled 'A study to understand the early stages of muscle weakness in people with Dys... Read More
Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN16931476) titled 'Pre-eclampsia prevention by timed birth at term 2 (PREVENT-2): a randomised... Read More